-
Mashup Score: 4Gene biomarker may predict gastric cancer survival, treatment response - Mayo Clinic Comprehensive Cancer Center Blog - 10 month(s) ago
Researchers have identified a gene biomarker associated with overall survival and treatment response in people with gastric cancer.
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Frontline Pembrolizumab Plus Trastuzumab/Chemo Improves PFS in HER2+ Advanced Gastric or GEJ Adenocarcinoma - 10 month(s) ago
The addition of pembrolizumab to trastuzumab and chemotherapy improved progression-free survival over trastuzumab and chemotherapy alone when used as a frontline regimen in patients with HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Checkpoint Inhibitors, FGFR Inhibitors Lead to Continued Advancements in Biliary Tract Cancer - 11 month(s) ago
James Harding, MD, highlighted current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial, the development of immunotherapy and chemotherapy combinations, and continued efforts to utilize personalized medicine in clinical practice.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1My Gut Feeling - Stomach Cancer Foundation of Canada - 12 month(s) ago
My Gut Feeling is the Stomach Cancer Foundation of Canada. We are a stomach cancer support network for patients, survivors and caregivers and we provide peer-to-peer support, education, awareness and advocacy for anyone affected by stomach cancer. Keywords: stomach cancer, gastric cancer, support gr
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Checkpoint Inhibitors, FGFR Inhibitors Lead to Continued Advancements in Biliary Tract Cancer - 12 month(s) ago
James Harding, MD, highlighted current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial, the development of immunotherapy and chemotherapy combinations, and continued efforts to utilize personalized medicine in clinical practice.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0H Pylori Eradication Therapy Curbs Risk for Stomach Cancer - 1 year(s) ago
Results of a large retrospective study support the potential for substantial stomach cancer prevention in the United States through H pylori screening and treatment.
Source: MedscapeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Improving nutrition for stomach cancer patients - 1 year(s) ago
There is currently no established guidelines for nutrition for stomach cancer patients, impacting their quality of life.
Source: TorontoCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Checkpoint Inhibitors, FGFR Inhibitors Lead to Continued Advancements in Biliary Tract Cancer - 1 year(s) ago
James Harding, MD, highlighted current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial, the development of immunotherapy and chemotherapy combinations, and continued efforts to utilize personalized medicine in clinical practice.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Removing risk of stomach cancer for her daughter - 1 year(s) ago
In late 2018, Estefania E. Marchan and her husband, Peter Richman, decided to start planning for a family. When Estefania’s obstetrician asked if the couple wanted to undergo cancer screening as part of the planning process, Estefania, who had a family history of stomach cancer, agreed. “It was pretty obvious to me that it was going to be something that was hereditary,” Estefania said.
Source: ccr.cancer.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Cancer of the Stomach - Cancer Stat Facts - 1 year(s) ago
Stomach Cancer statistics
Source: SEERCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
.@MayoCancerCare researchers have identified a gene biomarker associated with overall survival and treatment response in people with gastric cancer, also called #StomachCancer. Read more: https://t.co/3w93dduWdP